聯合醫務(00722.HK)成立創科中心 夥科大開發AI小護理應用程式
聯合醫務(00722.HK)宣布成立聯合醫務創科中心為開發者、專業醫療團隊及關心健康的大眾提供互相交流意見的平台,支援香港醫療應用科技及智慧健康科技的發展。
創科中心與香港科技大學簽訂研發合作協議,研發人工智能(AI)護理應用程式AI 小護理「為為」,讓病人獲得先進、貼身和個人化的照顧,該應用程式結合集團醫療團隊的資深專業知識和護理經驗和科大人工智能研發團隊的創新技術,以創新中心先行項目的姿態面向業界和公眾,讓醫護能夠透過智能數據及時關注病人的健康情況。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.